Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma?: A multicenter retrospective study in Japan

Cancer

Volumn 94, Issue 4, 2002, Pages 964-972

  Kosuda, Shigeru ^a   Yoshimura, Ichiro ^a   Aizawa, Taku ^b   Koizumi, Kiyoshi ^b   Akakura, Koichiro ^c   Kuyama, Junpei ^c   Ichihara, Kiyoshi ^d   Yonese, Junji ^e   Koizumi, Mitsuru ^e   Nakashima, Jun ^f   Fujii, Hirofumi ^f  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d KAWASAKI MEDICAL SCHOOL   (Japan)

^e CANCER INSTITUTE HOSPITAL   (Japan)

^f KEIO UNIVERSITY   (Japan)

Author keywords

Bone metastasis; Bone scintigraphy; Cost benefit analysis; Prostate carcinoma; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER LOCALIZATION; CANCER SCINTISCANNING; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BONE NEOPLASMS; CARCINOMA; DECISION MAKING; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 0037083357     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10340     Document Type: Article

References (19)

1. Prevention of cancers showing increasing trend in Japan
2. Using prostate-specific antigen to eliminate unnecessary diagnostic tests: Significant worldwide economic implications
3. Prostate-specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate
4. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer
5. Decision-tree sensitivity analysis for cost-effectiveness of chest FDG-PET in patients with a pulmonary nodule (nonsmall-cell lung carcinoma) in Japan
6. The threshold approach to clinical decision making
7. Methods of cost-effectiveness analysis: Areas of consensus and debate
8. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan
9. The importance of prognostic factors in advanced prostate cancer
10. Comparison of various assay systems for prostate-specific antigen standardization
11. Histopathological classification of prostate cancer
12. Cost-effectiveness analysis of prostatic cancer screening
13. The fourth annual nationwide survey of nuclear medicine examinations in Japan
14. The value of a baseline bone scan in patients with newly diagnosed prostate cancer
15. Local staging of prostate carcinoma: Comparison of transrectal sonography and endorectal MR imaging
16. Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: Correlation with histopathological results